Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona visit our website.
Company Details
- Employees
- 97
- Address
- 170 Harbor Way, South San Francisco,ca 94080,united States
- Phone
- (650) 799-6465
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- neuronatherapeutics.com
- HQ
- South San Francisco, CA
Neurona Therapeutics Questions
Neurona Therapeutics's helpline number is (650) 799-6465
Neurona Therapeutics's website is neuronatherapeutics.com
Neurona Therapeutics's LinkedIn profile is https://www.linkedin.com/company/neurona-therapeutics
Neurona Therapeutics has
97 employees.
View email and phone details for 97
employees at Neurona Therapeutics.
Neurona Therapeutics's industry is
Biotechnology Research
Neurona Therapeutics's top competitors are
Allogene Therapeutics,
Vertex Pharmaceuticals,
Latigo Biotherapeutics, Inc.,
Kyverna Therapeutics,
Bioage Labs,
Neuron23,
Arsenal Biosciences, Inc.,
Gilead Sciences,
Denali Therapeutics,
Genentech.
Neurona Therapeutics's categories are Biotechnology Research
